Riyaz Bashir retweeted
Balloon Pulmonary Angioplasty for Treatment of Chronic Thromboembolic Pulmonary Hypertension: Statement From the BPA-CTEPH Alliance jacc.org/doi/10.1016/j.jcin.…
Riyaz Bashir retweeted
We had a blast at I ♥️ @Phillies Heart & Vascular night celebrating our @TempleHealth #PulmonaryHypertension patient throwing the first ⚾️ pitch in excellent health! 🩺
Sorry @RedSox … it was a “W” for “PH” x 2️⃣❣️
🏆💚🔔🫀
Riyaz Bashir retweeted
Big News! The 544th—and final—patient has been enrolled in #HIPEITHO, a landmark RCT comparing EKOS + anticoagulation vs. anticoagulation alone in intermediate-high risk #PE. Thank you to our investigators, @PERTConsortium & @UnimedizinMainz. Learn more: bit.ly/44VQapx
Riyaz Bashir retweeted
@RiyazBashir and his team continue to make incredible strides with their research. This latest development could lead to major advancements in treating acute pulmonary embolism. Proud of their innovation and dedication to making a real difference in the lives of patients.
A novel “on-the-table” therapeutic strategy using the BASHIR™ Endovascular Catheter could eliminate the need for post-procedural drug infusion in an ICU. The cutting-edge technology was developed by @RiyazBashir and the #TempleMed team in collaboration with @ThrombolexTM.
Riyaz Bashir retweeted
2 landmark VTE trials ECLIPSED major milestones on this auspicious day! Congrats @moiz_hafiz and the SIU team for enrolling PE-TRACT participant number 100, on the same day that C-TRACT enrolled number 200. @PERTConsortium @SIRspecialists @WCMRadiology @VMJ_SVM @NATFthrombosis
Riyaz Bashir retweeted
To anyone who wrongly conflates Israel’s occupation with the Jewish people, know that hundreds of thousands of Israeli Jews oppose the occupation of Palestine & call for peaceful coexistence.
There is no excuse for antisemitism in any shape or form. ✡️❤️☪️
I AM SPEECHLESS. Many thousands of Jewish and Arab-Palestinian citizens of Israel are marching now in the Tel Aviv, demanding peace and an end to the occupation.
THE BIGGEST ANTI OCCUPATION RALLY IN YEARS. We have a peace and equality movement in Israel: @OMDIMBEYACHAD. WOW.
Riyaz Bashir retweeted
20 years ago, NBC journalist David Bloom passed away from a pulmonary embolism while embedded with American troops in Iraq. His widow Melanie joins TODAY to talk about her 20-year mission to raise awareness about blood clots. She is joined by @GBarnesMD to discuss risk factors.
Riyaz Bashir retweeted
Join Thrombolex today @ VEINS 2023 and discover how the BASHIR™ Family of Endovascular Catheters safely and effectively treats A+VTE. Learn more at Thrombolex.com.
#VEINSConference #Thrombolex
Riyaz Bashir retweeted
Attending VEINS 2023? Join us for an informative industry-sponsored break session 10/29 discussing the future of PM-CDT treatment for PE and Venous Disease, featuring Dr. Eric Secemsky. Register for VEINS 2023: viva-foundation.org/register
Thrombolex.com #Thrombolex
Riyaz Bashir retweeted
Please see our accompanying editorial where we highlight important innovations in catheter-based therapies of PE and suggest future directions for outcome measures in interventional PE trials sciencedirect.com/science/ar… @vakasullah @PERTConsortium
@RiyazBashir report PM-CDT with #BashirCatheter is associated with:
⬇️total and subtotal occlusion of segmental and proximal PAs
Reduction in segmental artery occlusions correlated with reduction in RV/LV ratio sciencedirect.com/science/ar…
@VladLakhter @krosenfieldMD @JACCJournals
Riyaz Bashir retweeted
New publication from the RESCUE trial for #PE Effect of Pharmacomechanical Catheter-Directed Thrombolysis on Segment... sciencedirect.com/science/ar…
Riyaz Bashir retweeted
Another meta-analysis? @PERTConsortium Catheter-directed thrombolysis compared with systemic thrombolysis and anticoagulation in patients with intermediate- or high-risk pulmonary embolism: systematic review and network meta-analysis cmaj.ca/content/195/24/E833
Here are the components of the SCAD score.
First SCAD risk assessment score for patients presenting with MI. Thanks for the guidance @RiyazBashir @VladLakhter and congrats to the team. #SCAD #myocardialinfarction #CardioTwitter #MedTwitter sciencedirect.com/science/ar…
Riyaz Bashir retweeted
Graduating Interventional Fellow Grand Rounds with our @TempleCards alum @AadharM @TempleGME @TempleHealth
Congrats Aadhar!
FDA approves endovascular catheter for the treatment of acute pulmonary embolism healio.com/news/cardiac-vasc…
Riyaz Bashir retweeted
The Bashir Endovascular Catheter, invented @templemedschool and developed @ThrombolexTM, has been approved by the @US_FDA for treatment of acute pulmonary embolism. Dr. @RiyazBashir, of @TempleHealth, is a co-inventor. Read more about the news here: templehealth.org/about/news/…
Riyaz Bashir retweeted
🏆 Kudos @MatthewYZhao! @AmerGastroAssn Abstract Award for Health Disparities Research at #DDW2023
Colorectal Cancer Rates at FQHC in the US from 2020 to 2021: Incomplete Rebound & Worsening Disparities
#MayLabUCLA: Yvonne Lei @meganrmcleod @jbadmph @DrGaloosianMD @drfolamay
Riyaz Bashir retweeted
Join us at 7:30 AM ET Wednesday for cath conference. @RiyazBashir will discuss refined balloon pulmonary angioplasty in CTEPH; Mauricio G. Cohen, MD, will discuss coronary and peripheral intervention malpractice lawsuits. Email [email protected] for registration link.
